Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -8.636M
March 31, 2026 18.03M
December 31, 2025 17.32M
September 30, 2025 24.48M
June 30, 2025 11.68M
March 31, 2025 22.64M
December 31, 2024 34.77M
September 30, 2024 24.98M
June 30, 2024 -7.688M
March 31, 2024 6.686M
December 31, 2023 -67.66M
September 30, 2023 -38.66M
June 30, 2023 -87.35M
March 31, 2023 -92.49M
December 31, 2022 -92.95M
September 30, 2022 -114.46M
June 30, 2022 -118.62M
March 31, 2022 -153.16M
December 31, 2021 -107.74M
September 30, 2021 -104.20M
June 30, 2021 -79.19M
March 31, 2021 -85.14M
December 31, 2020 -80.83M
September 30, 2020 -35.07M
June 30, 2020 -43.19M
Date Value
March 31, 2020 -43.02M
December 31, 2019 -17.47M
September 30, 2019 -13.59M
June 30, 2019 -4.576M
March 31, 2019 -32.77M
December 31, 2018 -14.92M
September 30, 2018 -23.81M
June 30, 2018 -35.92M
March 31, 2018 0.194M
December 31, 2017 -28.85M
September 30, 2017 -32.38M
June 30, 2017 -15.50M
March 31, 2017 -30.96M
December 31, 2016 -38.15M
September 30, 2016 -31.57M
June 30, 2016 -24.54M
March 31, 2016 -2.934M
December 31, 2015 -6.119M
September 30, 2015 -17.66M
June 30, 2015 -15.43M
March 31, 2015 -6.206M
September 30, 2014 5.597M
June 30, 2014 -3.712M
March 31, 2014 -7.64M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. -69.54M
CareDx, Inc. 28.75M
Myriad Genetics, Inc. -11.50M
BioRestorative Therapies, Inc. -3.808M
Exagen, Inc. 3.445M